1094 / 1816
FRACTIONATION
Similar trials from Colorado/Kansas/Virginia/Egypt
General: Patients with indication for loco-regional RT, BCS/mast,
morbidity is primary endpoint
Randomised trials:
Colorado: 40 Gy/15 fr versus 50 Gy/25 fr, target accrual 112 pts
Kansas: 40 Gy/15 fr versus 50 Gy/25 fr, target accrual 296 pts
Egypt: 42.5 Gy/16 fr versus 50 Gy/25 fr, target accrual 500 pts
Single arm study:
Virginia: 42.5 Gy/16 fr, target accrual 145 pts